Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for the coronavirus disease 2019 (COVID-19), has imposed unprecedented morbidity and mortality worldwide. As of June 2021, globally over 163… Click to show full abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for the coronavirus disease 2019 (COVID-19), has imposed unprecedented morbidity and mortality worldwide. As of June 2021, globally over 163 million individuals are infected and nearly 3.4 million individuals have died. Emerging concerns include complaints of persistent symptoms for extended periods in recovered individuals. Cellular damage due to disease and/or treatment, prolonged viral shedding, chronic immune inflammatory response, and pro-coagulant state induced by SARS-CoV-2 infection are suggested mechanisms contributing to the symptom sequelae (Estiri et al., 2021; Tran et al., 2021).
               
Click one of the above tabs to view related content.